DrMonica Barratt
Associate Professor
EnAble Institute
GRANTS
- Showing page 1 out of 1
- 1
Showing page 1, grant 1 to 1 of 1
- GRANTStrengthening Australia's response to our increasingly toxic unregulated drug supplyNational Health and Medical Research Council1 Jan 2026 - 31 Dec 2030Potent synthetic opioids have been recently detected across Australia resulting in deaths and nonfatal overdose outbreaks. Nitazenes - highly potent synthetic opioids - have been found represented as opioids as well as in non-opioid substances, such as cocaine and MDMA. The uptick in synthetic opioid detection has prompted concern that we are headed on the same deadly path as North America, which is experiencing an overdose crisis marked by unprecedented numbers of deaths from a potent and toxic unregulated drug supply. In response, Australian jurisdictions have launched drug checking (pill testing) services (DCS) in the ACT, then Qld, and soon-to-launch in Victoria. DCS offer the public the opportunity to submit drugs for chemical analysis and receive results alongside a health intervention. They empower people who use drugs to make informed decisions about their health, while also enabling communities and authorities to amplify public health alerts when toxic adulterations are detected. But there is still much we do not know. Knowledge gaps include: (1) the medium-to-long-term effectiveness of DCS on reducing drug harms, (2) the effects of the public outputs of DCS, (3) how best to leverage community experiences of toxic drug outbreaks, and (4) how best to reach diverse groups. My research will address these gaps by conducting mixed methods participatory research with different cohorts of drug consumers. I am the ideal applicant to lead this work due to the exceptional impact of my research and my enduring partnerships with service providers and lived-andliving- experience groups. Through this program, Australia will be better able to rapidly identify and respond to emerging drug threats. This new knowledge will be translated into improved drug checking service delivery and the amplification of drug market monitoring into more effective public communications, leading to reduced morbidity, mortality and family anguish, freeing up resources in our healthcare system.